Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Multiple Sclerosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Multiple Sclerosis
    TopAbstracts in Multiple Sclerosis 02/04/2010 - (DGNews)
    TopAbstracts in Multiple Sclerosis 01/26/2010 - (DGNews)
    A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis - (N Engl J Med)
    Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis - (N Engl J Med)
    A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis - (N Engl J Med)

    News archive

     Recent webcasts/CME - Multiple Sclerosis
    • Selecting Immunomodulating Therapy in Relapsing-Remitting Multiple Sclerosis
    • Delaying the Conversion of Clinically Isolated Syndrome to Relapsing-Remitting Multiple Sclerosis Through Early Intervention With Disease-Modifying Therapy
    • Delaying Disease Progression in Patients With MS Who Become Nonresponsive to Established Disease-Modifying Therapies
    • Multiple Sclerosis: Tempering Disabilities and Decline--Fundamentals for Managed Markets
      Evidence-Based Update for NPs and PAs in the Diagnosis and Management of Multiple Sclerosis

      Webcasts/CME archive

       Recent cases - Multiple Sclerosis
        Patient With Neuromyelitis Optica And Inflammatory Demyelinating Lesions Comprising Whole Spinal Cord From C2 Level Till Conus: Case Report
        Encephalomyelitis Mimicking Multiple Sclerosis Associated with Chronic Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation
        Progressive Primary Form of Multiple Sclerosis: Clinical and Radiological Improvement with Methylprednisolone in Continuous Pulsetherapy in One Case for 16 Years
        Burrowing of Urinary Bladder Wall by the Tip of a Size 22 Fr Silicone Foley Catheter in an Adult Male Patient With Multiple Sclerosis and Suprapubic Cystostomy: Should Caution be Exercised in Using a Size 22 Fr Silicone Foley Catheter for Long-Term Drainage of Neuropathic Bladder?
        Central Auditory Evaluation in Multiple Sclerosis: Case Report

        Cases archive
          




        my personal edition > multiple sclerosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        High Levels of Sun Exposure Prior to Age 15 Associated with Reduced Risk of Multiple Sclerosis

        British Medical Journal (BMJ)

        08/08/2003
        By Joene Hendry


        Higher levels of sun exposure during childhood and early adolescence and greater actinic damage are associated with a reduced risk of developing multiple sclerosis, according to results from the study of a population from Tasmania.

        A. F. van der Mei, a PhD student from the University of Tasmania, Hobart, Australia, and colleagues examined past sun exposure in 136 residents of Tasmania, younger than 60 years of age, with confirmed multiple sclerosis. They compared these data with past sun exposure levels in 272 age and gender matched controls. Overall, 68% of the cases were female and 95% of the study participants were born in Tasmania and lived there at age 10.

        Participants answered questions regarding life-long sun exposures, sun exposure protective measures and vitamin D supplements used, as well as medical history. The researchers correlated these data with past calendar measures of sunshine at Tasmania's latitude.

        The researchers found that greater levels of actinic damage, measured from the skin surface of participant's hands, were associated with a reduced risk for developing multiple sclerosis - adjusted odds ratios of 0.32, 0.33, and 0.17 for grade 4, 5, and 6, respectively, when compared with grade 3 multiple sclerosis.

        Additionally, higher sun exposure, consisting of 2 to 3 hours or more on average per day during the summer weekends and holidays while study participants were 6 to 15 years old, was associated with a decreased risk of developing multiple sclerosis (adjusted odds ratio of 0.31). Conversely, high levels of sun exposure obtained during the 1, 5, and 10 year period prior to developing multiple sclerosis did not show any evidence of a protective effect.

        The authors conclude, "The finding of no association between sun exposure in the decade before onset of multiple sclerosis may indicate that the timing of low exposure may relate more to age related immunological development than to onset of disease."
        BMJ 2003;327:316-20.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send